Pfizer Inc logo

PFE - Pfizer Inc Share Price

$37.6 0.4  1.2%

Last Trade - 15/04/21

Large Cap
Market Cap £152.14bn
Enterprise Value £172.34bn
Revenue £30.40bn
Position in Universe 46th / 6851
Unlock PFE Revenue
Relative Strength (%)
1m +1.11%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
48,851 52,824 52,546 40,825 41,172 41,908 62,585 53,456 -3.0%
-6.4 +35.7 +10.0 -54.7 +17.1 +42.5 +89.5 -8.26
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, PfizerInc. revenues increased 2% to $41.91B. Net incomeapplicable to common stockholders excluding extraordinaryitems decreased 34% to $6.99B. Revenues reflect RareDisease-Vyndaqel/Vyndamax segment increase from $473M to$1.29B, Internal Medicine-Eliquis alliance revenues anddirect sales segment increase of 17% to $4.95B, UnitedStates segment increase of 5% to $21.71B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PFE
Graphical History


PFE Revenue Unlock PFE Revenue

Net Income

PFE Net Income Unlock PFE Revenue

Normalised EPS

PFE Normalised EPS Unlock PFE Revenue

PE Ratio Range

PFE PE Ratio Range Unlock PFE Revenue

Dividend Yield Range

PFE Dividend Yield Range Unlock PFE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PFE EPS Forecasts Unlock PFE Revenue
Profile Summary

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated June 2, 1942
Public Since January 17, 1944
No. of Shareholders: 139,582
No. of Employees: 78,500
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 5,578,164,054
Free Float (0.0%)
Eligible for
PFE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PFE
Upcoming Events for PFE
Thursday 22nd April, 2021
Pfizer Inc Annual Shareholders Meeting
Friday 23rd April, 2021 Estimate
Pfizer Inc Annual Shareholders Meeting
Tuesday 4th May, 2021
Q1 2021 Pfizer Inc Earnings Release
Tuesday 4th May, 2021
Q1 2021 Pfizer Inc Earnings Call
Monday 26th July, 2021 Estimate
Q2 2021 Pfizer Inc Earnings Release
Frequently Asked Questions for Pfizer Inc
What is the Pfizer Inc share price?

As of 15/04/21, shares in Pfizer Inc are trading at $37.6, giving the company a market capitalisation of £152.14bn. This share price information is delayed by 15 minutes.

How has the Pfizer Inc share price performed this year?

Shares in Pfizer Inc are currently trading at $37.6 and the price has moved by 10.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Pfizer Inc price has moved by -25.16% over the past year.

What are the analyst and broker recommendations for Pfizer Inc?

Of the analysts with advisory recommendations for Pfizer Inc, there are there are currently 2 "buy" , 15 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Pfizer Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Pfizer Inc next release its financial results?

Pfizer Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Pfizer Inc dividend yield?

The Pfizer Inc dividend yield is 4.04% based on the trailing twelve month period.

Does Pfizer Inc pay a dividend?

Last year, Pfizer Inc paid a total dividend of 1.52, and it currently has a trailing dividend yield of 4.04%. Looking ahead, Pfizer Inc has not announced an ex-dividend date yet.

When does Pfizer Inc next pay dividends?

Pfizer Inc has yet to annouce their ex-dividend date. The historic dividend yield on Pfizer Inc shares is currently 4.04%.

How do I buy Pfizer Inc shares?

To buy shares in Pfizer Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Pfizer Inc?

Shares in Pfizer Inc are currently trading at $37.6, giving the company a market capitalisation of £152.14bn.

Where are Pfizer Inc shares listed? Where are Pfizer Inc shares listed?

Here are the trading details for Pfizer Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: PFE
What kind of share is Pfizer Inc?

Based on an overall assessment of its quality, value and momentum, Pfizer Inc is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Pfizer Inc share price forecast 2021?

Shares in Pfizer Inc are currently priced at $37.6. At that level they are trading at 8.09% discount to the analyst consensus target price of 0.00.

Analysts covering Pfizer Inc currently have a consensus Earnings Per Share (EPS) forecast of 3.317 for the next financial year.

How can I tell whether the Pfizer Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pfizer Inc. Over the past six months, the relative strength of its shares against the market has been -13.16%. At the current price of $37.6, shares in Pfizer Inc are trading at 5.16% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Pfizer Inc PE Ratio?

The Pfizer Inc PE ratio based on its reported earnings over the past 12 months is 21.49. The shares are currently trading at $37.6.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Pfizer Inc?

Pfizer Inc's management team is headed by:

Frank D'amelio - CFO
Sally Susman - EVP
Mikael Dolsten - CSO
Douglas Lankler - EVP
John Young - PRE
Shantanu Narayen - LED
Albert Bourla - CHM
Rady Johnson - EVP
Joseph Echevarria - IND
Ronald Blaylock - IND
Angela Hwang - CEX
Lidia Fonseca - EVP
Scott Gottlieb - IND
Susan Desmond-Hellmann - IND
Who are the major shareholders of Pfizer Inc?

Here are the top five shareholders of Pfizer Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.03% (448.0m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 5.01% (279.6m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.86% (271.3m shares)
Capital World Investors Investment Advisor
Percentage owned: 4.78% (266.6m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 4.42% (246.5m shares)
Similar to PFE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.